Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Percentile
P31
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-7.76%
202434582.75%
2023-100.49%
2022124.30%
2021-6.95%
20200.00%
2019100.00%
2018-295.50%
2017-149.61%
2016-697.92%